BrokersView
Search
Download
English
Sign In

Surgirux: Client Complaint Over Failed Withdrawal and Suspicious Tax Notice, Regulatory Warnings, Website Down

2025-04-29 BrokersView

BrokersView exposes Surgirux's fraudulent operations as client reports failed withdrawal

Surgirux, a forex broker flagged by multiple regulatory warnings, faces a client complaint over a stalled withdrawal request for a prolonged period and blocked account access.

 

According to the complaint, the trader deposited approximately 90,000 USDT on the Surgirux platform in mid-2024. However, when attempting to withdraw funds in September, the transaction remained in “processing” status within his personal account, and the money was never received. Repeated attempts to contact Surgirux’s support service went unanswered.

 

In January 2025, the trader logged into his account again and found his available balance showing the full amount, including purported earnings from trading activity on the platform. He said, “To date, the funds have not been received.”

 

complainant's withdrawal pages on the Surgirux platform

 

On April 24, 2025, the trader reported losing access to his account for seven days, with the system displaying a connection error.

 

Complainant Reports Suspicious Tax Notification 

 

The complainant also reported that following the failed withdrawal, he received a notification purportedly from "AMINABank Swiss," demanding a tax payment as a non-resident of Switzerland to complete the transaction. Upon closer examination of the email domain and other details, he determined that the message was fraudulent.

 

The trader's complaint does not indicate who issued the notice, raising the possibility that Surgirux is involved in a broader scheme to mislead and further exploit him. Many fake brokers have been known to use similar tactics to deceive investors into making additional transfers.

 

Surgirux is Unregulated

 

The Surgirux website is currently inaccessible. According to BrokersView's previous records, the platform's regulatory status page requires investors to provide an email address to access the information, an unusual practice that raises credibility concerns.

 

Surgirux's regulatory page needs the entry of an email to be checked

 

Additionally, Surgirux claims to hold a license from the Cyprus Securities and Exchange Commission (CySEC). However, CySEC has twice placed Surgirux on its warning list, contradicting this assertion.

 

Multiple Regulatory Warnings

 

In January and April 2025, the CySEC issued two separate warnings, flagging Surgirux as an unauthorized entity.

 

CySEC warns against Surgirux twice

 

On March 17, 2025, the Comisión Nacional del Mercado de Valores (CNMV) also added Surgirux to its warning list, citing its provision of investment services without proper authorization.

 

CNMV's warning list adds Surgirux

 

Bottomline

 

The complainant admitted to registering on Surgirux based on a recommendation, without independently verifying the platform’s licenses and regulatory status. BrokersView emphasizes the critical importance of conducting due diligence and confirming a trading platform’s legitimacy before investing funds.

 

Despite Surgirux’s ceased operations, scammers operating websites with short registration periods often resurface under a new identity. Therefore, investors must remain vigilant, as fraudulent platforms frequently rebrand with altered names and domains to commit fraud.

Share

Loading...